Development of Augmented Leukemia/Lymphoma-Specific T-Cell Immunotherapy for Deployment with Haploidentical, Hematompoietic Progenitor-Cell Transplant
Abstract
This is the final progress report for this grant application and describes our progress to date developing T cells with specificity for CD19.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2011
- Accession Number
- ADA560655
Entities
People
- Laurence Cooper
Organizations
- The University of Texas MD Anderson Cancer Center